N

Nordpharma

BE0749.928.180

Maria-Christinastraat 21 Brussel 1020
Financial ratios
2025
2024
2023
2022
2021
Gross margin
€ 270K
€ 280K
€ 289K
€ 227K
€ 258K
Profit
€ 49K
€ 80K
€ 78K
€ 54K
€ -2K
Equity
€ 543K
€ 495K
€ 465K
€ 435K
€ 418K
Employees
2.90
1.50
2.50
3.50
Credit limit
€ 131K
€ 251K
€ 255K
€ 213K
€ 129K
Taxes
€ 23K
€ 15K
€ 15K
€ 7K
Salaries and Social Security Contributions
€ 6K
€ 26K
€ 19K
€ 16K
€ 14K
Dividends
€ 50K
€ 48K
€ 36K
Dividend payout
62.79%
61.87%
67.26%
EBITDA
€ 126K
€ 141K
€ 143K
€ 126K
€ 47K
EBIT
€ 67K
€ 90K
€ 89K
€ 64K
€ -473
Net profit
€ 49K
€ 80K
€ 78K
€ 54K
€ -2K
Capex
€ 66K
€ 42K
€ 28K
€ 64K
Cash
€ 87K
€ 104K
€ 84K
€ 89K
€ 50K
Cashflow
€ 107K
€ 130K
€ 131K
€ 116K
€ 45K
Working capital
€ 39K
€ 44K
€ 52K
€ 66K
€ 38K
Current ratio
1.15
1.16
1.21
1.25
1.20
Quick ratio
0.94
1
0.94
1.03
0.80
Working capital ratio
1.15
1.16
1.21
1.25
1.20
Assets
€ 811K
€ 784K
€ 748K
€ 778K
€ 639K
Debt
€ 268K
€ 290K
€ 283K
€ 342K
€ 221K
Short-term debt
€ 261K
€ 269K
€ 248K
€ 260K
€ 189K
Long-term debt
€ 7K
€ 21K
€ 35K
€ 82K
€ 32K
Solvability
67.01%
63.06%
62.15%
56.00%
65.40%
Long term debt ratio
0.01
0.04
0.07
0.19
0.08
Debt / EBITDA
2.13
2.06
1.99
2.71
4.69
Interest Coverage Ratio
Gross profitability
19.70%
26.29%
28.18%
26.53%
10.89%
Net profitability
8.97%
16.10%
16.68%
12.29%
-0.50%
Return On Assets (ROA)
6.01
10.15
10.37
6.88
-0.33
Return On Equity (ROE)
8.97
16.10
16.68
12.29
-0.50
Customer credit
16.08
16.99
45.33
19.79
Supplier credit
Days Sales Outstanding (DSO)
16.08
16.99
45.33
19.79
Days Sales of Inventory (DSI)
17.47
15.04
24.91
19.09
19.56
Inventory Turnover Ratio
23.15
19.13
15.76
16.52
37.33
Employees
2.90
1.50
2.50
3.50
Staff cost per employee
€ 2K
€ 13K
€ 6K
€ 4K